Cheng LI
10Patents
1h-index
27Co-inventors
46Inventor score
Filing activity: Jun 2, 2017 → Dec 14, 2021
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US11459323B2 | Monocyclic β-lactam compound for treating bacterial infection | Human Necessities | 1 | Active |
| US10738051B2 | β-lactamase inhibitors | Emerging Cross-Sectional Technologies | 0 | Active |
| US12325732B2 | Pro-insulin aspart structure and method for preparing insulin aspart | Chemistry; Metallurgy | 0 | Active |
| US11518819B2 | Anti-angiogenesis fusion protein and uses thereof | Chemistry; Metallurgy | 0 | Active |
| US12338263B2 | Antibacterial aminoglycoside derivatives | Emerging Cross-Sectional Technologies | 0 | Active |
| US12054561B2 | Anti-angiogenesis fusion protein and uses thereof | Chemistry; Metallurgy | 0 | Active |
| US11390677B2 | Human anti-CD47 antibodies and uses thereof | Chemistry; Metallurgy | 0 | Active |
| US10683487B2 | Myrmecridium flexuosum NUK-21, novel lactose oxidase isolated from Myrmecridium flexuosum NUK-21, and method for conversion of lactose into lactobionic acid by novel lactose oxidase | Chemistry; Metallurgy | 0 | Active |
| US11180501B2 | Crystal form of β-lactamase inhibitor and preparation method therefor | Chemistry; Metallurgy | 0 | Active |
| US10851146B2 | Method for preparing liraglutide intermediate polypeptide | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.